Of these trials, four compared DPP-4 inhibitors against placebo (SAVOR-TIMI 53, EXAMINE, TECOS, CARMELINA), eight compared GLP-1RA against placebo (ELIXA, LEADER, SUSTAIN-6, EXSCEL, HARMONY, REWIND, PIONEER 6, AMPLITUTE-O) and eleven compared SGLT-2 inhibitors against placebo (EMPA-REG, CANVAS, DECLARE, CREDENCE, DAPA-HF, DAPA CKD, VERTIS-CV, EMPEROR-R, SCORED, SOLOIST-WHF, EMPEROR-P)
Evidence for their claimed effects comes primarily from marketing materials and customer testimonials rather than controlled clinical trials
1 KPV minimized intestinal inflammation in a murine colitis model when delivered via the PepT1 transporter in colonic epithelial cells
FAQs About BPC-157 for Tendon Healing 1
PubMed laboratory research record [PMID: 5172688] PubMed record related to this compound for laboratory literature review
Improvements in insulin sensitivity and reductions in chronic low-grade inflammation may enhance the anabolic responsiveness of skeletal muscle to dietary protein and resistance exercise